Drugs / OPK-88006
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07512427 | Dec 2026 → Dec 2027 expected | — | OPKO Health, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPK-88006 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07512427 ↗ |
| Route | Subcutaneous | “Administered by subcutaneous injection” NCT07512427 ↗ |